Summary
Overview
Work History
Education
Skills
Accomplishments
Software
Recent Publications
Timeline

Kiel Peck

Study Director
Los Angeles,CA

Summary

Driven biomedical researcher with more than 10 years of advanced basic science, translational medicine, and analysis experience. Successful in applying Design of Experiment techniques to break down multiple data types and draw logical conclusions to enhance production efficiencies and drug product efficacy. Proven talents in pre-clinical study management and cGMP process development. Skilled in working with deadlines and adapting to emergent challenges within the pre-clinical space. Looking to transition to a challenging new role in the CRO space by applying investigational experience and the latest technology to tackle new projects and ideas.

Overview

15
15
years of professional experience
8
8
years of post-secondary education

Work History

PhD Graduate Student

Cedars-Sinai Medical Center
Los Angeles, United States
09.2018 - 03.2021
  • Designed, managed, and executed in vitro and in vivo studies supporting the investigation of therapeutic extracellular vesicles.
  • Established and maintained transgenic mammalian cell cultures from primary tissues and transformed cell lines.
  • Performed routine data analysis, bioinformatics, and manuscript preparation.
  • Logistical management of all study materials and animal colonies.
  • Prepared grant proposals and applications to public and private entities for funding and contractual purposes.
  • Prepared and presented bi-monthly research in progress updates.

Associated Director Product Development

Capricor Inc.
Beverly Hills, CA
12.2014 - 10.2018
  • Oversaw extracellular vesicle product development. Pre-clinical study design, management, and material manufacturing.
  • Implemented process scale-up solutions supporting rapid expansion or production and program proliferation from concept to reality.
  • Designed and coordinated processes applicable to numerous projects for design efficiency and continuity.
  • Translated information highly technical in nature to executive staff and aligned product characteristics with company goals

Process Development Associate III

Organogenesis Inc.
Caton, MA
03.2006 - 11.2014
  • Evaluated current processes to develop improvement plans.
  • Optimized tissue-to-product manufacturing processes for engineered skin product.
  • Authored and reviewed cGMP batch records and management strategies to reinforce and protect product quality.
  • Assisted with FDA inspections and document audits.

Education

Ph.D. - Biomedical Sciences And Translational Medicine

Cedar-Sinai Medical Center, Los Angeles, CA
09.2018 - 03.2022

Bachelor of Science - Biology

Pacific University, Forest Grove, OR
09.1998 - 05.2003

Skills

    Good Laboratory Practices (GLP)

Research grants

Method validation

Experiment Design

Quantitative analysis

Bioinformatics

Accomplishments

  • Managed a team of 5 in the development of clinical manufacturing processes for therapeutic extracellular vesicles.
  • Lead the development of a novel purification and drug-product formulation process for Cardiosphere Cell-derived exosomes
  • Developed a serum-free cell culture process for the production of the analogous skin replacement product Apligraf.

Software

Microsoft Office

Microsoft Project

R-studio

Prism

Recent Publications

1. Peck K., Ciullo A., Li L., et al. TDO2-Augmented Fibroblasts Secrete EVs with Immune-Regulating yRNA. (in preparation)

2. Peck K., Ciullo A., Li L., et al. Extracellular Vesicles Secreted by TDO2-Augmented Fibroblasts Regulate Pro-Inflammatory Response in Macrophages. Front Cell Dev Biol,. .:733354. Published 2021, Oct 22. doi:10.3389/fcell.2021.733354

3. Ciullo A., Peck K., et al. Biodistribution of unmodified cardiosphere-derived cell EVs using single RNA tracing. Journal of Extracellular Vesicles. (accepted, December 12, 2021) doi: 10.1002/jev2.12178

4. Rogers RG., Li L., Peck K., Sanchez L., Liu W., Ciullo A., Alfaro J., Rannou A., Fournier M., Lee Y., Marbán E., Cardiosphere-derived cells, with and without a biological scaffold, stimulate myogenesis and recovery of muscle function in mice with volumetric muscle loss. Biomaterials. 2021 Jul;274:120852. doi: 10.1016/j.biomaterials.2021.120852. Epub 2021 Apr 27. PMID: 33951565.

A full accounting of publications will be made available upon request.

Timeline

PhD Graduate Student - Cedars-Sinai Medical Center
09.2018 - 03.2021
Cedar-Sinai Medical Center - Ph.D., Biomedical Sciences And Translational Medicine
09.2018 - 03.2022
Associated Director Product Development - Capricor Inc.
12.2014 - 10.2018
Process Development Associate III - Organogenesis Inc.
03.2006 - 11.2014
Pacific University - Bachelor of Science, Biology
09.1998 - 05.2003
Kiel PeckStudy Director